Search by Drug Name or NDC
NDC 63287-0419-01 RELEEV Cold Sore Treatment 1.3 mg/mL Details
RELEEV Cold Sore Treatment 1.3 mg/mL
RELEEV Cold Sore Treatment is a TOPICAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Merix Pharmaceutical Corp.. The primary component is BENZALKONIUM CHLORIDE.
Product Information
NDC | 63287-0419 |
---|---|
Product ID | 63287-419_e3da5cc2-c71d-3a22-e053-2995a90adfeb |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | RELEEV Cold Sore Treatment |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Benzalkonium Chloride |
Product Type | HUMAN OTC DRUG |
Dosage Form | LIQUID |
Route | TOPICAL |
Active Ingredient Strength | 1.3 |
Active Ingredient Units | mg/mL |
Substance Name | BENZALKONIUM CHLORIDE |
Labeler Name | Merix Pharmaceutical Corp. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH NOT FINAL |
Application Number | part333A |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 63287-0419-01 (63287041901)
NDC Package Code | 63287-419-01 |
---|---|
Billing NDC | 63287041901 |
Package | 1 POUCH in 1 BLISTER PACK (63287-419-01) / 1 BOTTLE, DROPPER in 1 POUCH / 1 mL in 1 BOTTLE, DROPPER |
Marketing Start Date | 2006-06-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf Details
Uses:
Warnings:
For external use only
Do Not Use:
• If you have ever had an allergic reaction to this product or any of its ingredients. • Do not swallow. • Do not use for yeast infections (may be used in conjunction with yeast medication). • Avoid contact with eyes. • If condition worsens or does not improve, contact a health care professional.
When Using This Product
• Use only as directed • Brief tingling may occur.
SPL UNCLASSIFIED SECTION
Directions:
Inactive Ingredients:
Other Information:
INGREDIENTS AND APPEARANCE
RELEEV COLD SORE TREATMENT
benzalkonium chloride liquid |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Labeler - Merix Pharmaceutical Corp. (158385687) |
Revised: 7/2022
Document Id: e3da5cc2-c71d-3a22-e053-2995a90adfeb
Set id: fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf
Version: 17
Effective Time: 20220715